536 related articles for article (PubMed ID: 20687883)
1. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice.
Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Yanai K
Peptides; 2005 May; 26(5):767-77. PubMed ID: 15808907
[TBL] [Abstract][Full Text] [Related]
3. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
4. Orexin receptors: pharmacology and therapeutic opportunities.
Scammell TE; Winrow CJ
Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
[TBL] [Abstract][Full Text] [Related]
5. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
6. A review of the role of orexin system in pain modulation.
Razavi BM; Hosseinzadeh H
Biomed Pharmacother; 2017 Jun; 90():187-193. PubMed ID: 28360013
[TBL] [Abstract][Full Text] [Related]
7. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain.
Cheng JK; Chou RC; Hwang LL; Chiou LC
J Pharmacol Exp Ther; 2003 Dec; 307(3):1065-71. PubMed ID: 14551290
[TBL] [Abstract][Full Text] [Related]
8. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
Borgland SL; Storm E; Bonci A
Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
[TBL] [Abstract][Full Text] [Related]
9. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
10. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A; Del Bello F; Giorgioni G; Piergentili A; Saab E; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Quaglia W
Med Res Rev; 2023 Sep; 43(5):1607-1667. PubMed ID: 37036052
[TBL] [Abstract][Full Text] [Related]
11. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
[TBL] [Abstract][Full Text] [Related]
12. Orexin receptor subtype activation and locomotor behaviour in the rat.
Samson WK; Bagley SL; Ferguson AV; White MM
Acta Physiol (Oxf); 2010 Mar; 198(3):313-24. PubMed ID: 19889100
[TBL] [Abstract][Full Text] [Related]
13. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
14. Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex.
Shahid IZ; Rahman AA; Pilowsky PM
Br J Pharmacol; 2012 Apr; 165(7):2292-303. PubMed ID: 21951179
[TBL] [Abstract][Full Text] [Related]
15. Orexins and appetite regulation.
Rodgers RJ; Ishii Y; Halford JC; Blundell JE
Neuropeptides; 2002 Oct; 36(5):303-25. PubMed ID: 12450737
[TBL] [Abstract][Full Text] [Related]
16. Orexins and the treatment of obesity.
Smart D; Haynes AC; Williams G; Arch JR
Eur J Pharmacol; 2002 Apr; 440(2-3):199-212. PubMed ID: 12007536
[TBL] [Abstract][Full Text] [Related]
17. [Orexins and pain processing].
Yamamoto T; Shono K
Masui; 2007 Jan; 56(1):40-7. PubMed ID: 17243644
[TBL] [Abstract][Full Text] [Related]
18. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
Lee HJ; Chang LY; Ho YC; Teng SF; Hwang LL; Mackie K; Chiou LC
Neuropharmacology; 2016 Jun; 105():577-586. PubMed ID: 26907809
[TBL] [Abstract][Full Text] [Related]
19. Functions of the orexinergic/hypocretinergic system.
Kukkonen JP; Holmqvist T; Ammoun S; Akerman KE
Am J Physiol Cell Physiol; 2002 Dec; 283(6):C1567-91. PubMed ID: 12419707
[TBL] [Abstract][Full Text] [Related]
20. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.
Ziolkowska A; Spinazzi R; Albertin G; Nowak M; Malendowicz LK; Tortorella C; Nussdorfer GG
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):423-9. PubMed ID: 16157481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
